INNV
InnovAge Holding Corp. Common Stock
SERVICES-HEALTH SERVICES
Best Health Services Stocks 2026 →
InnovAge (INNV) Stock: Buy, Sell, or Hold?
$9.34
-0.03 (-0.37%)
âŧ
5d:
-4.65%
30d:
+3.49%
90d:
-12.35%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (72%)
Quality Score
47/100
Position
FAIR
30-Day Fair Range
$8.92 â $9.33
Position: FAIR
Forward P/E & Valuation
18.7x
CHEAP
vs 25.4x historical avg
Wall Street Target
$12.00
+28.1% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$8.78 / $9.91
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: INNV is fairly priced but lacks strong directional signals. At -9.6% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Get Alerted When INNV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$24.34
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$15.11
38.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: INNV is currently trading at $9.34, which is considered fair relative to its 30-day fair value range of $8.92 to $9.33. From a valuation perspective, the stock is trading at a discount (Forward PE: 18.7) compared to its historical average (25.4). Remarkably, the market is currently pricing in an annual earnings decline of 9.6% over the next few years. This pessimistic expectation contrasts with the company's recent 136.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, INNV is in a strong downtrend. Immediate support is located at $8.78, while resistance sits at $9.91.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+28.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INNV is in a strong downtrend. Immediate support is located at $8.78, while resistance sits at $9.91.
Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.00 (+28.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$8.92 -
$9.33
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Trading Range & Key Levels
30-Day Trading Range
$8.92 -
$9.33
Current vs Trading Range
FAIR
Support Level
$8.78
Resistance Level
$9.91
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 28.1% below Wall St target ($12.00)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
18.74
Wall Street Target
$12.00
(+28.1%)
Revenue Growth (YoY)
12.1%
Earnings Growth (YoY)
136.7%
Profit Margin
0.9%
Valuation Discount vs History
-9.6% cheaper
PE vs Historical
18.7 vs 25.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-9.6%
(market-implied from PE analysis)
1-Year Target
$8.47
(-10%)
2-Year Target
$7.66
(-18%)
3-Year Target
$6.92
(-26%)
3-Yr Target (if PE normalizes)
(PE: 19â25)
$9.38
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 38.9%)
$26.60
(+184%)
Base:
(SPY PE: 18.7, Growth: 38.9%)
$25.10
(+168%)
Bear:
(PE: 15.9, Growth: 38.9%)
$21.34
(+128%)
đ
Valuation based on Current Earnings
Forward PE: 13.66 | Forward EPS (Implied): $0.69
Bull Case
$11.31
(+21%)
Analyst growth 15.0%, PE expands to 14.3
Base Case
$9.37
(0%)
Market implied 0.0%, PE stable at 13.7
Bear Case
$7.17
(-24%)
Severe decline -15.0%, PE contracts to 12.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 18.7 to 25.4
Stabilization Target:
$12.70
(+35.5%)
PE Expansion Potential:
+35.5%
Share INNV Analysis
Share this live INNV analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INNV)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 4, 2026
Daily AI digest
AI Retail Discussion Summary:
Bullish sentiment dominates $INNV on StockTwits with no new news articles available.
Key Retail Themes:
Bullish sentiment
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:58 AM ET
Data refreshes hourly during market hours. Next update: 10:58 AM
Data refreshes hourly during market hours. Next update: 10:58 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INNV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare CorporaâĻ |
STRONG BUY
23 analysts |
$306 | 47 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
16 analysts |
$24 | 55 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
26 analysts |
$477 | 39 SELL |
|
EHC
Encompass Health Corp |
STRONG BUY
13 analysts |
$156 | 34 SELL |
|
CON
Concentra Group HoldingsâĻ |
STRONG BUY
11 analysts |
$44 | 41 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INNV Research Pages
